Digital-commerce-in-pharmaceuticals: Difference between revisions

A public knowledge platform on B2B digital commerce
No edit summary
No edit summary
Line 22: Line 22:
* McKinsey, 2021 [https://www.mckinsey.com/industries/healthcare/our-insights/the-future-of-healthcare-value-creation-through-next-generation-business-models The future of healthcare: Value creation through next-generation business models]
* McKinsey, 2021 [https://www.mckinsey.com/industries/healthcare/our-insights/the-future-of-healthcare-value-creation-through-next-generation-business-models The future of healthcare: Value creation through next-generation business models]
* McKinsey, 2023 [https://www.mckinsey.com/industries/life-sciences/our-insights/rewired-pharma-companies-will-win-in-the-digital-age Rewired pharma companies will win in the digital age]
* McKinsey, 2023 [https://www.mckinsey.com/industries/life-sciences/our-insights/rewired-pharma-companies-will-win-in-the-digital-age Rewired pharma companies will win in the digital age]
* B2B wave, 2018 [https://www.b2bwave.com/p/why-b2b-ecommerce-is-an-opportunity-for-medical-and-pharmaceutical-wholesalers Why B2B eCommerce Is an Opportunity for Medical and Pharmaceutical Wholesalers]
* BioPharmaTrend, 2019 [https://www.biopharmatrend.com/post/69-the-next-big-thing-in-the-life-sciences-rd-market-e-commerce/ How E-commerce Reshapes Pharmaceutical R&D Market]





Revision as of 08:05, 8 April 2024

Articles for review


Postponed


<- Back to collections roadmap